News
12-15-2014, 03:16 AM
In patients with metastatic triple-negative breast cancer--a disease with no approved targeted therapies--infusion of pembrolizumab produced durable responses in almost one out of five patients...
More... (http://www.medicalnewstoday.com/releases/286848.php)
More... (http://www.medicalnewstoday.com/releases/286848.php)